Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Acute Mesenteric Venous Thrombosis
NCT03483207Unknown
- Sponsor
- Assiut University
- Start
- Apr 2018
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Open-label, single-arm trial of heparin and warfarin in Mesenteric venous thrombosis (MVT), sponsored by Assiut University. Primary endpoint: Anticoagulation therapy (heparin & warfarin) in MVO. Status: unknown.
02
Drugs
heparinwarfarin
03
Conditions
Mesenteric venous thrombosis (MVT)
Beyond the preview
Go deeper on NCT03483207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03483207.